News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Mohamed Abdelaziz: Atezolizumab and Bevacizumab versus Sorafenib in Egyptian HCC patients
Abdallah Khalil, Mohamed Abdelaziz and Tamer El Nahas
Dec 20, 2024, 09:06

Mohamed Abdelaziz: Atezolizumab and Bevacizumab versus Sorafenib in Egyptian HCC patients

Mohamed Abdelaziz, National Oncology Committee member at Ministry of Health and Population in Egypt and Intern Fellow at Gustave Roussy, shared on LinkedIn:

“Thrilled to share the publication of our recent poster presented in ESMO ASIA.

Tackling the benefit of atezo/beva vs sorafenib in Egyptian HCC patients.”

235P Combined atezolizumab and bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma: A single center experience

Authors: A.A. Khalil, M.A. Abdelaziz, T.I. El Nahas

Mohamed abdelaziz
Further Reading:

Highlights from Day 1 of ESMO Asia 2024

Highlights from Day 2 of ESMO Asia 2024

Highlights from Day 3 of ESMO Asia 2024

Best of ESMO Asia 2024

Abdallah Khalil Atezolizuma Bevacizumab cancer ESMO Asia 2024 Hepatocellular carcinoma (HCC) Mohamed Abdelaziz OncoDaily Oncology sorafenib Tamer El Nahas
Special Coverage
Societies
Sep 5, 2025, 03:27
Europe’s Progress on the Early Detection of Prostate Cancer - European Cancer Organization
Voices
Sep 5, 2025, 03:11
Sumanta Pal: What Role Does Metabolism Play in Cancer Progression and Treatment?
Voices
Sep 5, 2025, 03:08
Polikalipo Kagina: Strengthening Radiotherapy Awareness and Support
Insight
Sep 5, 2025, 03:04
Luca Boldrini: A New Era in Radiation Oncology
Voices
Sep 5, 2025, 02:17
Advancing Pediatric Leukemia Research in 2025 - St. Jude Children's Research Hospital
Voices
Sep 4, 2025, 23:59
Roberto Borea: Selected Liquid Biopsy Abstracts for WCLC25
Insight
Sep 4, 2025, 20:03
Aruni Ghose: AI-Enhanced Medical Imaging for Cancer Diagnosis
Insight
Sep 4, 2025, 19:35
A Reminder That Education Is Essential to Patient Care - Elekta
Dialogues
Sep 4, 2025, 18:19
MASCC 2025 Presidential Training Fellowship Spotlight: Dr. Colleen Ann Cuthbert
Immune Oncology
Sep 4, 2025, 16:49
LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC
OncoDaily Pulse
Sep 4, 2025, 16:17
Mariam Sargsyan: Meet the Experts of VIRO 2025
Voices
Sep 4, 2025, 15:59
Markus Kosch: Finding Strength After Diagnosis - A Conversation with Claudia Poguntke